Czech Life Sciences Legal Updates

Life Sciences Legal Update - Q1 2024

March 27, 2024

Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.

Life Sciences Legal Update - Q1 2024 (Czech)

March 27, 2024

Czech Republic: We bring you the first 2024 edition of the quarterly Life Science Legal Update, in which we regularly cover key legal aspects and innovations in the Pharmaceuticals and Life Sciences sectors. The first quarter of 2024 is full of news in the pharmaceutical, healthcare services and food sectors. For instance, there has been much discussion about limiting the availability of HHC substances to consumers; in addition, several implementing regulations for the amendment to the Medicines Act have come into force as well as a new pricing regulation under which health insurers will now be able to request a maximum price for a specific medicinal product as part of an exceptional reimbursement regime. The EU is about to negotiate the draft pharmaceutical package presented by the European Commission. Last but not least, the major amendment to the Significant Market Power Act which has been newly effected, and which largely affects buyer-supplier relationships in the supply of food, agricultural products and other related services.

Life Science Legal Update Q3 2023 (Czech)

November 13, 2023

Czech Republic: Life Sciences Legal Update offers you insights into the most recent legislative developments affecting the amendments to the Medicines Act and Health Services Act. We also inform you about fines recently imposed by the Office for the Protection of Competition and the State Institute for Drug Control, the decree regarding new requirements for the sale of coffee, tea and coffee products as well as the ban on the sale of distinctive flavors in heated tobacco products.

Life Sciences Legal Update - Q3 2023

November 13, 2023

Czech republic: Life Science Legal Update offers you insights into the most recent legislative developments affecting the amendments to the Medicines Act and Health Services Act. We also inform you about fines recently imposed by the Office for the Protection of Competition and the State Institute for Drug Control, the decree regarding new requirements for the sale of coffee, tea and coffee products as well as the ban on the sale of distinctive flavors in heated tobacco products.

Life Sciences Legal Update - Q2 2023 (Czech)

August 7, 2023

Czech Republic: Life Sciences Legal Update offers you insights into the most important legal changes and news in the pharmaceuticals and life sciences sector. In this issue, we look at the cancellation of the food worker's health cards, the new pharmaceutical strategy of the European Commission, and the current situation with regard to the ban on CBD sales.

Life Sciences Legal Update - Q2 2023

August 7, 2023

Czech Republic: Life Sciences Legal Update offers you insights into the most important legal changes and news in the pharmaceuticals and life sciences sector. In this issue, we look at the cancellation of the food worker's health cards, the new pharmaceutical strategy of the European Commission, and the current situation with regard to the ban on CBD sales.

Life Sciences Legal Update - Q1 2023 (Czech)

April 14, 2023

Czech Republic: Welcome to our regular quarterly edition of the Life Sciences Legal Update, which focuses on key news and events in the life sciences sector in the first quarter of 2023. Find out what new regulations, court decisions and trends are impacting the pharmaceutical and healthcare law landscape in the Czech Republic, and what implications this may have for your business.

Life Sciences Legal Update - Q1 2023

April 14, 2023

Czech Republic: Welcome to our regular quarterly edition of the Life Sciences Legal Update, which focuses on key news and events in the life sciences sector in the first quarter of 2023. Find out what new regulations, court decisions and trends are impacting the pharmaceutical and healthcare law landscape in the Czech Republic, and what implications this may have for your business.

Life Sciences Legal Update - Q3 2022

December 5, 2022

Czech Republic: December is here, and that means another Legal Update full of Pharmaceuticals & Life Sciences news. We'll start with positive news, including a decision by the State Institute for Drug Control (SÚKL) on new reimbursement options for orphan drugs and the long-awaited law on single-use plastics, which aims to significantly lighten the burden on the environment. The Pharmaceuticals Act and the amendment to the Advertising Regulation Act have not escaped further updates. More clear rules for the production and trade of cannabis are provided by the implementing legislation for the Addictive Substances Act. Last but not least, you can read about the planned changes being discussed in the Chamber of Deputies, which are expected to affect the Advertising Regulation Act as well as the Public Health Protection Act.

Life Sciences Legal Update - Q3 2022 (Czech)

December 5, 2022

Czech Republic: December is here, and that means another Legal Update full of Pharmaceuticals & Life Sciences news. We'll start with positive news, including a decision by the State Institute for Drug Control (SÚKL) on new reimbursement options for orphan drugs and the long-awaited law on single-use plastics, which aims to significantly lighten the burden on the environment. The Pharmaceuticals Act and the amendment to the Advertising Regulation Act have not escaped further updates. More clear rules for the production and trade of cannabis are provided by the implementing legislation for the Addictive Substances Act. Last but not least, you can read about the planned changes being discussed in the Chamber of Deputies, which are expected to affect the Advertising Regulation Act as well as the Public Health Protection Act.